{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:42:09Z","timestamp":1790890929895,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Hospital Management Project of the Eastern Theater Command General Hospital","award":["22LCZLXJS65"],"award-info":[{"award-number":["22LCZLXJS65"]}]},{"name":"the Hospital Management Project of the Eastern Theater Command General Hospital","award":["2023LCZLXC057"],"award-info":[{"award-number":["2023LCZLXC057"]}]},{"DOI":"10.13039\/501100005145","name":"Basic Research Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20242093"],"award-info":[{"award-number":["BK20242093"]}],"id":[{"id":"10.13039\/501100005145","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Hospital Management Project of the Eastern Theater Command General Hospital","award":["22LCZLXJS65"],"award-info":[{"award-number":["22LCZLXJS65"]}]},{"name":"the Hospital Management Project of the Eastern Theater Command General Hospital","award":["2023LCZLXC057"],"award-info":[{"award-number":["2023LCZLXC057"]}]},{"DOI":"10.13039\/501100005145","name":"Basic Research Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20242093"],"award-info":[{"award-number":["BK20242093"]}],"id":[{"id":"10.13039\/501100005145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Belimumab is approved for treating systemic lupus erythematosus (SLE) in children over 5\u00a0years old; however, its efficacy and safety in pediatric SLE patients require further validation. This study aimed to\u00a0evaluate\u00a0the\u00a0impact\u00a0of belimumab on the long-term cumulative probability of sustained renal response\u00a0and\u00a0disease flare\u00a0in children with lupus nephritis (LN),\u00a0to inform clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included a total of 96 children with LN in our study. The patients were part of a prospective cohort study and were divided into two groups: belimumab group (68 cases) and standard treatment (group (28 cases). We compared remission rates, flare rates, and adverse event incidence between these two\u00a0groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After 152\u00a0weeks of follow-up, belimumab increased the renal response and complete renal response rates by 16.7% [odds ratios (OR)\u2009=\u20095.38 (1.33, 15.12)] and 24.7% [OR\u2009=\u20092.74 (1.04, 7.19)]. Belimumab significantly reduced the risk of LN flare, with a 46.2% lower flare rate in the belimumab group compared to the standard treatment group. There was no significant difference in long-term cumulative probability of complete remission between the belimumab and standard treatment groups (P\u2009=\u20090.081), and\u00a0the\u00a0standard treatment group had a higher flare rate (P\u2009=\u20090.004).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adding belimumab to\u00a0standard treatment may effectively maintain long-term kidney function and reduce LN flares, making it an effective and safe biologic agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-025-02397-0","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:21:57Z","timestamp":1763058117000},"page":"2939-2948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sustained renal response with belimumab in children with new-onset lupus nephritis"],"prefix":"10.1093","volume":"38","author":[{"given":"Ren","family":"Wang","sequence":"first","affiliation":[{"name":"https:\/\/ror.org\/059gcgy73 grid.89957.3a 0000 0000 9255 8984 Department of Pediatrics, Jinling Hospital Nanjing Medical University Nanjing China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Shi","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Fang","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhuining","family":"Kuang","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/059gcgy73 grid.89957.3a 0000 0000 9255 8984 Department of Pediatrics, Jinling Hospital Nanjing Medical University Nanjing China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/04kmpyd03 grid.440259.e 0000 0001 0115 7868 Department of Pediatrics Jinling Hospital Nanjing China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiQiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/059gcgy73 grid.89957.3a 0000 0000 9255 8984 Department of Pediatrics, Jinling Hospital Nanjing Medical University Nanjing China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-8766","authenticated-orcid":false,"given":"Zhengkun","family":"Xia","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/059gcgy73 grid.89957.3a 0000 0000 9255 8984 Department of Pediatrics, Jinling Hospital Nanjing Medical University Nanjing China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Gao","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/059gcgy73 grid.89957.3a 0000 0000 9255 8984 Department of Pediatrics, Jinling Hospital Nanjing Medical University Nanjing China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[{"name":"https:\/\/ror.org\/059gcgy73 grid.89957.3a 0000 0000 9255 8984 Department of Pediatrics, Jinling Hospital Nanjing Medical University Nanjing China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"11","key":"2026020606021297900_CR1","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026020606021297900_CR2"},{"key":"2026020606021297900_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108898","article-title":"Classification of systemic lupus erythematosus in children and adults","volume":"234","author":"Lythgoe","year":"2022","journal-title":"Clin Immunol"},{"key":"2026020606021297900_CR4"},{"key":"2026020606021297900_CR5"},{"key":"2026020606021297900_CR6","doi-asserted-by":"publisher","first-page":"1118180","DOI":"10.3389\/fimmu.2022.1118180","article-title":"Editorial: Systemic lupus erythematosus\u2014predisposition factors, pathogenesis, diagnosis, treatment and disease models","volume":"13","author":"Nandakumar","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"2026020606021297900_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40620-020-00816-y","article-title":"Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases","volume":"34","author":"Wang","year":"2021","journal-title":"J Nephrol"},{"key":"2026020606021297900_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae575","article-title":"Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab","author":"Parodis","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026020606021297900_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108907","article-title":"Systemic lupus erythematosus\u2014are children miniature adults?","volume":"234","author":"Alexander","year":"2022","journal-title":"Clin Immunol"},{"issue":"11","key":"2026020606021297900_CR10","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.2215\/CJN.02520322","article-title":"Safety and efficacy of belimumab in patients with lupus nephritis: open-label extension of BLISS-LN study","volume":"17","author":"Furie","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2026020606021297900_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.kint.2021.08.027","article-title":"A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis","volume":"101","author":"Rovin","year":"2022","journal-title":"Kidney Int"},{"issue":"10","key":"2026020606021297900_CR12","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","article-title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial","volume":"79","author":"Brunner","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2026020606021297900_CR13","doi-asserted-by":"publisher","first-page":"2072143","DOI":"10.1080\/21645515.2022.2072143","article-title":"Belimumab for systemic lupus erythematosus\u2014focus on lupus nephritis","volume":"18","author":"Pluss","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2026020606021297900_CR14","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2147\/DDDT.S216193","article-title":"Management of pediatric systemic lupus erythematosus: focus on belimumab","volume":"14","author":"Guzman","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"2026020606021297900_CR15"},{"key":"2026020606021297900_CR16"},{"issue":"9767","key":"2026020606021297900_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"2026020606021297900_CR18","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/acr.24901","article-title":"Impact of belimumab on organ damage in systemic lupus erythematosus","volume":"74","author":"Urowitz","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"2026020606021297900_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/jcph.104","article-title":"Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus","volume":"53","author":"Struemper","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2026020606021297900_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001350","article-title":"Efficacy of initial combination with belimumab in newly diagnosed childhood-onset lupus nephritis: a single-centre historical control study","volume":"11","author":"Gong","year":"2024","journal-title":"Lupus Sci Med"},{"issue":"48","key":"2026020606021297900_CR21","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3760\/cma.j.cn112137-20220302-00438","article-title":"Efficacy and safety of belimumab treatment in childhood-onset systemic lupus erythematosus","volume":"102","author":"Kang","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"2026020606021297900_CR22","article-title":"Belimumab for systemic lupus erythematosus","volume":"2","author":"Singh","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2026020606021297900_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/annrheumdis-2017-211631","article-title":"A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea","volume":"77","author":"Zhang","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02397-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/38\/9\/2939\/66793826\/joneph_38_9_2397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/38\/9\/2939\/66793826\/joneph_38_9_2397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:02:20Z","timestamp":1770375740000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/9\/2939\/8462672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02397-0","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,1]]},"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complies with the Declaration of Helsinki and has been approved by the Institutional Ethics Committee of Nanjing Medical University (approval number 2023DZYNKT-001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients and their families were fully informed about the study procedures and provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}